Header Logo

Connection

NADER EL-MALLAWANY to Humans

Back to Details
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Humans.
NADER EL-MALLAWANY
Connection Strength
0.522
Humans
  1. Peripheral T-cell lymphoma-NOS in children and adolescents: a?review from the Children's Oncology Group NHL Committee. Blood Adv. 2025 Mar 25; 9(6):1420-1431.
    View in: PubMed
    Score: 0.026
  2. EBV and post-transplant lymphoproliferative disorder: a complex relationship. Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):728-735.
    View in: PubMed
    Score: 0.026
  3. Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 11 22; 8(22).
    View in: PubMed
    Score: 0.024
  4. Evolving beyond morphology in pediatric PTLD. Blood. 2023 08 03; 142(5):400-402.
    View in: PubMed
    Score: 0.024
  5. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30565.
    View in: PubMed
    Score: 0.023
  6. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
    View in: PubMed
    Score: 0.023
  7. Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203.
    View in: PubMed
    Score: 0.021
  8. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol. 2022 01; 196(1):31-44.
    View in: PubMed
    Score: 0.020
  9. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020 08 25; 4(16):4007-4019.
    View in: PubMed
    Score: 0.019
  10. Checkmate for EBV-HLH. Blood. 2020 03 12; 135(11):782-784.
    View in: PubMed
    Score: 0.019
  11. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev. 2019 12; 38(4):749-758.
    View in: PubMed
    Score: 0.018
  12. Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
    View in: PubMed
    Score: 0.018
  13. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116.
    View in: PubMed
    Score: 0.017
  14. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7.
    View in: PubMed
    Score: 0.016
  15. Identifying opportunities to bridge disparity gaps in curing childhood cancer in Malawi: Malignancies with excellent curative potential account for the majority of diagnoses. Pediatr Hematol Oncol. 2017 Aug; 34(5):261-274.
    View in: PubMed
    Score: 0.016
  16. Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi. Clin Infect Dis. 2017 03 15; 64(6):818-819.
    View in: PubMed
    Score: 0.015
  17. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
    View in: PubMed
    Score: 0.014
  18. Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2015 Feb; 13(2):113-23.
    View in: PubMed
    Score: 0.013
  19. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. Eur J Cancer. 2015 Jan; 51(1):92-100.
    View in: PubMed
    Score: 0.013
  20. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant. 2011 May; 46(5):759-61.
    View in: PubMed
    Score: 0.010
  21. Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011-2020. Pediatr Blood Cancer. 2025 Jul; 72(7):e31669.
    View in: PubMed
    Score: 0.007
  22. High-Dose Methotrexate Usage Without Drug-Level Monitoring in Advanced Pediatric Mature B-Cell Non-Hodgkin Lymphoma in a Resource-Limited Setting in Malawi. JCO Glob Oncol. 2025 Mar; 11:e2400591.
    View in: PubMed
    Score: 0.007
  23. Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer. 2024 Jul 15; 130(14):2416-2439.
    View in: PubMed
    Score: 0.006
  24. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1888-1893.
    View in: PubMed
    Score: 0.006
  25. Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1882-1887.
    View in: PubMed
    Score: 0.006
  26. Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Jul-Aug; 27(4):348-353.
    View in: PubMed
    Score: 0.006
  27. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024 Apr 08; 42(4):605-622.e11.
    View in: PubMed
    Score: 0.006
  28. Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448.
    View in: PubMed
    Score: 0.006
  29. Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2023 01; 64(1):234-237.
    View in: PubMed
    Score: 0.006
  30. Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas. Pediatr Blood Cancer. 2022 11; 69(11):e29940.
    View in: PubMed
    Score: 0.006
  31. Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766.
    View in: PubMed
    Score: 0.005
  32. Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania. Pediatr Hematol Oncol. 2022 Feb; 39(1):28-47.
    View in: PubMed
    Score: 0.005
  33. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. Int J STD AIDS. 2020 07; 31(8):724-734.
    View in: PubMed
    Score: 0.005
  34. Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. BMC Infect Dis. 2020 Apr 25; 20(1):309.
    View in: PubMed
    Score: 0.005
  35. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019 08; 66(8):e27798.
    View in: PubMed
    Score: 0.004
  36. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
    View in: PubMed
    Score: 0.004
  37. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):141-148.
    View in: PubMed
    Score: 0.004
  38. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer. 2018 Mar; 26(3):967-973.
    View in: PubMed
    Score: 0.004
  39. Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4).
    View in: PubMed
    Score: 0.004
  40. Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment. Br J Haematol. 2018 06; 181(6):853-854.
    View in: PubMed
    Score: 0.004
  41. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol. 2017 05; 177(4):601-611.
    View in: PubMed
    Score: 0.004
  42. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer. 2017 06 01; 140(11):2509-2516.
    View in: PubMed
    Score: 0.004
  43. Quantifying bias in survival estimates resulting from loss to follow-up among children with lymphoma in Malawi. Pediatr Blood Cancer. 2017 06; 64(6).
    View in: PubMed
    Score: 0.004
  44. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.004
  45. Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):637-50.
    View in: PubMed
    Score: 0.004
  46. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol. 2016 06; 173(5):705-12.
    View in: PubMed
    Score: 0.004
  47. Tumoral bacillary angiomatosis in a child with human immunodeficiency virus. JAMA Dermatol. 2014 Sep; 150(9):1015-6.
    View in: PubMed
    Score: 0.003
  48. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S6-13.
    View in: PubMed
    Score: 0.003
  49. Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa. Nat Rev Clin Oncol. 2013 10; 10(10):599-604.
    View in: PubMed
    Score: 0.003
  50. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
    View in: PubMed
    Score: 0.003
  51. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol. 2012 Jan; 156(1):99-108.
    View in: PubMed
    Score: 0.003
  52. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.
    View in: PubMed
    Score: 0.003
  53. Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings. Pediatr Dev Pathol. 2011 Jan-Feb; 14(1):28-37.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.